Skip to content
Ontario Rheumatology Association
  • Login
  • Login
  • About
    • Overview
    • Organizational Priorities and Committees
    • Leadership
    • Annual Awards
  • Events
  • EAP & Limited Use Codes
    • Overview
    • Exceptional Access Program
    • EAP Forms and Downloads
    • Limited Use Codes
    • Biosimilar Fact Sheet
    • NIHB Drug List
    • MOHLTC IVIG Request Form
  • Informatics
    • Rheumatology EMR Database at ICES
  • Members
    • Overview
    • Member Directory
    • Peer Mentor Forum
    • Resource for Members
    • Become A Member
    • Renew Membership
    • Membership Perks
  • News
    • Overview
    • Drug Shortages Info
    • Newsletters
    • Other Publications
    • Info Hub
  • Contact
  • Directory
  • Login
  • About
    • Overview
    • Organizational Priorities and Committees
    • Leadership
    • Annual Awards
  • Events
  • EAP & Limited Use Codes
    • Overview
    • Exceptional Access Program
    • EAP Forms and Downloads
    • Limited Use Codes
    • Biosimilar Fact Sheet
    • NIHB Drug List
    • MOHLTC IVIG Request Form
  • Informatics
    • Rheumatology EMR Database at ICES
  • Members
    • Overview
    • Member Directory
    • Peer Mentor Forum
    • Resource for Members
    • Become A Member
    • Renew Membership
    • Membership Perks
  • News
    • Overview
    • Drug Shortages Info
    • Newsletters
    • Other Publications
    • Info Hub
  • Contact
  • Directory

President’s Message

Philip Baer • Edition: Summer 2020

Week 3 as ORA President already, and I can say there is never a dull moment. We are 3 months+ into the pandemic in Ontario, with all the challenges that has entailed. ORA members pivoted immediately to virtual care in mid-March. Now working from home seems normal, and if you have made even a rare foray into the office for in-person care, it is the venue that feels strange. Not to mention uncomfortable with all the PPE required, if you can even source what you need.

As you know, we ran 5 ORA Town Halls through April and May to update members on the evolving situation. All of these are archived on the ORA website (Members-only portion), where we also house links to multiple COVID-19 resources, including financial and infection control information. Special thanks to Mark Atkinson of Ardeane for managing the platform, together with Sandy Kennedy, our hard-working ORA Project Manager, and Dr. Felix Leung, our Communications chair and now VP-Adult. Over 100 members attended on each occasion.

Unfortunately, our ORA Annual Scientific meeting (ASM) fell victim to the pandemic. Both EULAR and ACR 2020 have gone virtual, as have all ORA Board and committee meetings, and our mid-June retreat. We will continue to review plans for a 2021 ASM depending on the course of the pandemic.

In the background, all ORA committees continue to function and deal with their mandates. Drug shortages, informatic advances, biosimilars, and transitions in and out of practice are key areas we are focused on. A new Northern Ontario committee has been created from the RheumOpps group, chaired by Sahil Koppikar.

I know you are frustrated by the issues around virtual care, particularly the limitations of OTN, and the ongoing battle to ensure E078 can be billed with K083. ORA leaders have been lobbying furiously with both the OMA and government. Special thanks to Jane Purvis, now our Past-President, who led this effort through the spring. At this time, the issue is still at the negotiations table, with arbitration a possibility if agreement cannot be reached.

Our new ORA Board and Executive were approved at one of the Town Halls and took over their roles as of May 25, 2020. I want to extend special thanks to our 3 departing board members for their hard work on your behalf: Drs Vandana Ahluwalia, Rick Adachi and Vinod Chandran. We welcome to the ORA Board Drs. Shelly Dunne, Raman Rai and Faiza Khokhar. All of us will be working hard on behalf of the ORA membership and their patients during these challenging times.

Other Articles in the Summer 2020 Newsletter

  • Invitation from ACPAC Special Interest Group of the AHPA
  • RheumOpportunities Update
  • OMA Update
  • Communications Update
  • Executive Director Update
  • MOH News
  • ORADE Report: Dr. Anas Makhzoum
  • ORADE Report: Dr. Vikram Tangri
Editions
  • Winter 2021
  • Fall 2020
  • Summer 2020
  • Winter 2020
  • Winter 2019
  • Fall 2019
  • Spring 2019
  • Winter 2018
  • Fall 2018
  • Summer 2018
  • Summer 2017
  • Spring 2017
  • Fall 2017
  • Archive
  • Meet the Speakers: ORA 20th Annual Scientific Meeting
Committees
Communications Informatics Models of Care OMA
Tags
Biosimilar CSDTH Models of Care OBRI OMA pCPA SADIE

Contributors

The ORA’s executive members are the core contributors to the newsletter. The ORA welcomes guest contributions to the newsletter from members-at-large and others in the rheumatology community.

Contributors
Ontario Rheumatology Association

© 2020 Ontario Rheumatology Association. All Rights Reserved. Website by Digital Chaos Inc.

  • About
  • Annual Awards
  • Events
  • EAP & Limited Use Codes
  • Exceptional Access Program
  • EAP Forms and Downloads
  • Limited Use Codes
  • Biosimilar Fact Sheet
  • NIHB Drug List
  • MOHLTC IVIG Request Form
  • Informatics
  • Members
  • Member Directory
  • Past Meeting Resources
  • Peer Mentor Forum
  • BecomeA Member
  • Renew Membership
  • News
  • Newsletters
  • Drug Shortages Info
  • Other Publications
  • Info Hub
  • Contact
  • Privacy